• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Catalog Number CLXECP
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/29/2023
Event Type  malfunction  
Event Description
The customer contacted mallinckrodt to report they experienced a bag leak with their cellex photopheresis kit ("kit") during an extracorporeal photopheresis (ecp) treatment.The customer reported they observed the treatment bag was leaking from the needle free injection port during the photoactivation phase of the procedure.The ecp treatment was aborted and no residual blood within the kit was returned to the patient.The customer reported the patient was in stable condition.The customer will return the kit and photographs for investigation.
 
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction bag leak.Since this reportable malfunction is only associated with the kit, this mdr will only be against the kit.A batch record review for kit lot l155 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot l155 shows no trends.Trends were reviewed for complaint category, bag leak.No trends were detected for this complaint category.At the time of this report, the analysis of the returned kit and photographs is still in process.A final report will be filed when the analysis is complete.(b)(4).(b)(6).
 
Manufacturer Narrative
The complaint kit, smart card and photographs were provided by the customer for evaluation.Smart card data showed that buffy coat collection phase began after 1489ml of whole blood had been processed.Multiple alarm #48: treatment bag - air detected alarms occurred during photoactivation phase of the treatment, before the treatment was aborted by the operator.Evaluation of the customer provided photographs verified the bag leak as blood is seen leaking from the treatment bag.In addition, the needle-free port is seen with a puncture mark through the port.The treatment bag was the only part of the kit returned for examination.The treatment bag was pressure tested to check for leaks and a leak was verified at the needle-free port.The puncture mark to the needle-free port is consistent with damage that occurs if the operator uses a needle to inject medication into the treatment bag.A material trace of the port and its components used to build lot l155 found no related non-conformances.The device history record (dhr) review did not identify any related non-conformances, deviations, or equipment maintenance events.This kit lot passed all lot release testing.The damage to the needle-free port is consistent with the use of a needle on the needle-free port; however, the customer reported they did not use a needle.The root cause of the bag leak could not be determined based on the available information.No further action is required at this time.The investigation is now complete.(b)(4) 01-feb-2024.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
blanchardstown, dublin, D15 T X2V
EI  D15 TX2V
Manufacturer (Section G)
HARMAC MEDICAL PRODUCTS
i.d.a. business park
castlerea roscommon,
EI  
Manufacturer Contact
mark wendelken
440 route 22 east
suite 302
bridgewater, NJ 08807
MDR Report Key17996488
MDR Text Key326394123
Report Number3013428851-2023-00061
Device Sequence Number1
Product Code LNR
Combination Product (y/n)Y
Reporter Country CodeSW
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 02/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/24/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberCLXECP
Device Lot NumberL155
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer10/05/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/05/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-